Hypoxia-Inducible Factor Augments Experimental Colitis Through an MIF-Dependent Inflammatory Signaling Cascade

Gastroenterology

Volumn 134, Issue 7, 2008, Pages

  Shah, Yatrik M ^a   Ito, Shinji ^a   Morimura, Keiichirou ^a   Chen, Chi ^a   Yim, Sun Hee ^a   Haase, Volker H ^b   Gonzalez, Frank J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; HYPOXIA INDUCIBLE FACTOR; MIGRATION INHIBITION FACTOR; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL MIGRATION; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOLOGY; IMMUNITY; MACROPHAGE; MEDICAL TECHNOLOGY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 44649179392     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.03.009     Document Type: Article

References (53)

1. Wang G.L., and Semenza G.L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 90 (1993) 4304-4308
2. Wang G.L., Jiang B.H., Rue E.A., et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92 (1995) 5510-5514
3. Semenza G.L., and Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12 (1992) 5447-5454
4. Wang G.L., and Semenza G.L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 268 (1993) 21513-21518
5. Tian H., McKnight S.L., and Russell D.W. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11 (1997) 72-82
6. Makino Y., Cao R., Svensson K., et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414 (2001) 550-554
7. Jaakkola P., Mole D.R., Tian Y.M., et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
8. Ivan M., Kondo K., Yang H., et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292 (2001) 464-468
9. Haase V.H., Glickman J.N., Socolovsky M., et al. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci U S A 98 (2001) 1583-1588
10. Hu C.J., Wang L.Y., Chodosh L.A., et al. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation. Mol Cell Biol 23 (2003) 9361-9374
11. Pugh C.W., and Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9 (2003) 677-684
12. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3 (2003) 721-732
13. Lee D.W., and Andersen J.K. Role of HIF-1 in iron regulation: potential therapeutic strategy for neurodegenerative disorders. Curr Mol Med 6 (2006) 883-893
14. Iyer N.V., Kotch L.E., Agani F., et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12 (1998) 149-162
15. Tian H., Hammer R.E., Matsumoto A.M., et al. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 12 (1998) 3320-3324
16. Maltepe E., Schmidt J.V., Baunoch D., et al. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386 (1997) 403-407
17. Gnarra J.R., Ward J.M., Porter F.D., et al. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc Natl Acad Sci U S A 94 (1997) 9102-9107
18. Karhausen J., Furuta G.T., Tomaszewski J.E., et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 114 (2004) 1098-1106
19. Neurath M., Fuss I., and Strober W. TNBS-colitis. Int Rev Immunol 19 (2000) 51-62
20. Wirtz S., Neufert C., Weigmann B., et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2 (2007) 541-546
21. Goyette P., Labbe C., Trinh T.T., et al. Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine. Ann Med 39 (2007) 177-199
22. Strober W., Fuss I., and Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 117 (2007) 514-521
23. Ponda P.P., and Mayer L. Mucosal epithelium in health and disease. Curr Mol Med 5 (2005) 549-556
24. el Marjou F., Janssen K.P., Chang B.H., et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39 (2004) 186-193
25. Baugh J.A., Gantier M., Li L., et al. Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1. Biochem Biophys Res Commun 347 (2006) 895-903
26. Tomita S., Ueno M., Sakamoto M., et al. Defective brain development in mice lacking the Hif-1alpha gene in neural cells. Mol Cell Biol 23 (2003) 6739-6749
27. Tomita S., Sinal C.J., Yim S.H., et al. Conditional disruption of the aryl hydrocarbon receptor nuclear translocator (Arnt) gene leads to loss of target gene induction by the aryl hydrocarbon receptor and hypoxia-inducible factor 1alpha. Mol Endocrinol 14 (2000) 1674-1681
28. Ito S., Chen C., Satoh J., et al. Dietary phytochemicals regulate whole-body CYP1A1 expression through an arylhydrocarbon receptor nuclear translocator-dependent system in gut. J Clin Invest 117 (2007) 1940-1950
29. Shah Y.M., Morimura K., and Gonzalez F.J. Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis. Am J Physiol Gastrointest Liver Physiol 292 (2007) G657-G666
30. Suzuki M., Sugimoto H., Nakagawa A., et al. Crystal structure of the macrophage migration inhibitory factor from rat liver. Nat Struct Biol 3 (1996) 259-266
31. Kaidi A., Qualtrough D., Williams A.C., et al. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res 66 (2006) 6683-6691
32. Warner T.D., and Mitchell J.A. Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic. FASEB J 18 (2004) 790-804
33. Wouters E.F. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2 (2005) 26-33
34. Black H., Mendoza M., and Murin S. Thoracic manifestations of inflammatory bowel disease. Chest 131 (2007) 524-532
35. Rachmilewitz D., Karmeli F., Okon E., et al. Hyperbaric oxygen: a novel modality to ameliorate experimental colitis. Gut 43 (1998) 512-518
36. Yu A.Y., Shimoda L.A., Iyer N.V., et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1alpha. J Clin Invest 103 (1999) 691-696
37. Cramer T., Yamanishi Y., Clausen B.E., et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112 (2003) 645-657
38. Scortegagna M., Cataisson C., Martin R.J., et al. HIF-1{alpha} regulates epithelial inflammation by cell autonomous NF{kappa}B activation and paracrine stromal remodeling. Blood 111 (2008) 3343-3354
39. Robinson A., Keely S., Karhausen J., et al. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134 (2008) 145-155
40. Cummins E.P., Seeballuck F., Keely S.J., et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134 (2008) 156-165
41. Synnestvedt K., Furuta G.T., Comerford K.M., et al. Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest 110 (2002) 993-1002
42. Comerford K.M., Wallace T.J., Karhausen J., et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 62 (2002) 3387-3394
43. Furuta G.T., Turner J.R., Taylor C.T., et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 193 (2001) 1027-1034
44. Gordan J.D., Bertout J.A., Hu C.J., et al. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11 (2007) 335-347
45. Wiesener M.S., Turley H., Allen W.E., et al. Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood 92 (1998) 2260-2268
46. Uchida T., Rossignol F., Matthay M.A., et al. Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. J Biol Chem 279 (2004) 14871-14878
47. Graven K.K., Bellur D., Klahn B.D., et al. HIF-2alpha regulates glyceraldehyde-3-phosphate dehydrogenase expression in endothelial cells. Biochim Biophys Acta 1626 (2003) 10-18
48. de Jong Y.P., Abadia-Molina A.C., Satoskar A.R., et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2 (2001) 1061-1066
49. Ohkawara T., Nishihira J., Takeda H., et al. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 123 (2002) 256-270
50. Ohkawara T., Nishihira J., Ishiguro Y., et al. Resistance to experimental colitis depends on cytoprotective heat shock proteins in macrophage migration inhibitory factor null mice. Immunol Lett 107 (2006) 148-154
51. Ohkawara T., Miyashita K., Nishihira J., et al. Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis. Clin Exp Immunol 140 (2005) 241-248
52. Al-Abed Y., Dabideen D., Aljabari B., et al. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J Biol Chem 280 (2005) 36541-36544
53. Hewitson K.S., and Schofield C.J. The HIF pathway as a therapeutic target. Drug Discov Today 9 (2004) 704-711